Metabolic supplementation with enhanced external counterpulsation improves myocardial function in acquired cardiomyopathy: a case report.
BACKGROUND
Cardiomyopathy is reflected in a deterioration of heart function, increased risk of developing arrhythmias, and the potential for sudden cardiac death. The use of enhanced external counterpulsation has been recommended for treating chronic stable angina in high-risk surgical patients. Furthermore, cells require adequate levels of adenosine triphosphate for the maintenance of integrity and function. Lower myocardial levels of adenosine triphosphate are commonly found with ischemia and heart failure. d-Ribose, a natural occurring carbohydrate, enhances the regeneration of adenosine triphosphate levels and improves diastolic function following ischemia.


METHODS
We present a patient with cardiomyopathy and marked reduced cardiac function.


CONCLUSIONS
This patient underwent enhanced external counterpulsation and metabolic supplementation, including d-ribose, and achieved a significant functional improvement.
Brookman
Robert H
RH
Anti-aging Health Institute, Inc., Greensboro, GA 30642, USA.
St Cyr
John A
JA
D000368:Aged; D009202:Cardiomyopathies / Q000517:prevention & control / Q000628:therapy*; D003131:Combined Modality Therapy; D015908:Counterpulsation / Q000379:methods*; D019587:Dietary Supplements; D004452:Echocardiography; D006333:Heart Failure / Q000517:prevention & control; D006801:Humans; D008297:Male; D009200:Myocardial Contraction; D011788:Quality of Life; D012266:Ribose / Q000008:administration & dosage*; D016896:Treatment Outcome; D014451:Ubiquinone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014815:Vitamins / Q000008:administration & dosage*
D014815:Vitamins; D014451:Ubiquinone; D012266:Ribose; C024989:coenzyme Q10